Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 118,444 clinical trials worldwide
Search
Showing 95351-95400 of 118,444 trials
Active filters:
Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting
Clinical Trials (118,444)
NCT05002543
CORCYM Mitral, Aortic aNd Tricuspid Post-maRket Study in a reAl-world Setting
N/A
Recruiting
2,150 participants
Started: Jun 29, 2021 · Completed: Dec 31, 2035
1 condition
1 sponsor
52 locations
NCT04599478
Pharmacological and Behavioral Treatment After Bariatric Surgery: Acute (Stage 1)
PHASE2/PHASE3
Recruiting
160 participants
Started: Jun 29, 2021 · Completed: Jan 31, 2027
2 conditions
2 sponsors
1 location
NCT04942431
REBIRTH Active School 2.0 . a School Based Physical Activity Program
NA
Active, not recruiting
1,245 participants
Started: Jun 28, 2021 · Completed: Dec 30, 2025
1 condition
1 sponsor
1 location
NCT04906200
Web-Based Symptom Monitoring and Self-Management Portal (YES) for Adolescent and Young Adult Breast Cancer Survivors
NA
Active, not recruiting
400 participants
Started: Jun 28, 2021 · Completed: Aug 31, 2026
22 conditions
4 sponsors
3 locations
NCT04569097
Novel Pharyngeal Metrics to Predict Dysphagia Outcomes
NA
Active, not recruiting
222 participants
Started: Jun 28, 2021 · Completed: Sep 30, 2025
2 conditions
1 sponsor
3 locations
NCT04925752
Study of Lenacapavir for HIV Pre-Exposure Prophylaxis in People Who Are at Risk for HIV Infection
PHASE3
Active, not recruiting
3,292 participants
Started: Jun 28, 2021 · Completed: May 31, 2028
1 condition
1 sponsor
91 locations
NCT04634643
Pathogenesis of Pediatric Nonalcoholic Fatty Liver Disease (NAFLD)
N/A
Recruiting
260 participants
Started: Jun 28, 2021 · Completed: Jan 30, 2026
1 condition
2 sponsors
1 location
NCT04846478
Phase Ia/Ib Talazoparib + Tazemetostat for mCRPC
PHASE1
Active, not recruiting
35 participants
Started: Jun 28, 2021 · Completed: Sep 30, 2026
2 conditions
4 sponsors
2 locations
NCT04647227
SEVENFACT® for Bleeding Events in Hemophilia With Inhibitors
PHASE4
Recruiting
55 participants
Started: Jun 28, 2021 · Completed: Mar 31, 2027
2 conditions
2 sponsors
22 locations
NCT04444440
Antibiotic Prophylaxis for Bladder Botox
PHASE4
Recruiting
202 participants
Started: Jun 28, 2021 · Completed: Jun 30, 2026
2 conditions
2 sponsors
1 location
NCT04481555
Eosinophil-guided Reduction of Inhaled Corticosteroids
PHASE4
Recruiting
444 participants
Started: Jun 28, 2021 · Completed: Dec 31, 2026
5 conditions
1 sponsor
9 locations
NCT04601038
Trial of CORT108297 to Attenuate the Effects of Acute Stress in the Allocortex (CORT-X)
PHASE2
Recruiting
52 participants
Started: Jun 28, 2021 · Completed: Jan 1, 2027
3 conditions
2 sponsors
1 location
NCT04736485
Perioperative Treatment in Resectable Gastric Cancer With Spartalizumab (PDR001) in Combination With Fluorouracil, Leucovorin, Oxaliplatin, and Docetaxel (FLOT)
PHASE2
Active, not recruiting
67 participants
Started: Jun 28, 2021 · Completed: Mar 31, 2027
2 conditions
2 sponsors
13 locations
NCT04936607
ImproviNg rEnal Outcomes Following Coronary angiograPhy and/or percuTaneoUs coroNary intErventions
NA
Recruiting
1,158 participants
Started: Jun 28, 2021 · Completed: Jul 31, 2027
1 condition
3 sponsors
1 location
NCT04770012
AERIAL Trial: Antiplatelet Therapy in Heart Transplantation
PHASE3
Recruiting
135 participants
Started: Jun 28, 2021 · Completed: Mar 31, 2029
2 conditions
2 sponsors
3 locations
NCT05581511
Natural History Study of Cutaneous Neurofibromas in People With NF1
N/A
Active, not recruiting
500 participants
Started: Jun 28, 2021 · Completed: Jun 30, 2029
4 conditions
2 sponsors
1 location
NCT04837092
Phase I/II Study of FR104 First Administration in Patient with Renal Transplantation: FIRsT Study
PHASE1/PHASE2
Active, not recruiting
10 participants
Started: Jun 28, 2021 · Completed: Mar 31, 2025
1 condition
2 sponsors
1 location
NCT04725994
Study to Assess the Safety, Tolerability, and Efficacy of IDX-1197 in Combination with XELOX or Irinotecan in Patients with Advanced Gastric Cancer
PHASE1/PHASE2
Recruiting
100 participants
Started: Jun 28, 2021 · Completed: Jun 30, 2026
1 condition
1 sponsor
14 locations
NCT04921631
Integrated Supportive and Palliative Care for Older Adults in the ICU
NA
Active, not recruiting
1,400 participants
Started: Jun 28, 2021 · Completed: May 31, 2026
1 condition
3 sponsors
1 location
NCT04817449
Spectroscopy in Ovarian Cancer
N/A
Active, not recruiting
160 participants
Started: Jun 28, 2021 · Completed: Oct 31, 2025
4 conditions
2 sponsors
1 location
NCT04660214
Minimally Invasive Endoscopic Treatment of Zenker's Diverticulum Comparing LigaSureTM vs SB-Knife.
NA
Recruiting
80 participants
Started: Jun 28, 2021 · Completed: Dec 31, 2026
3 conditions
1 sponsor
1 location
NCT04579224
Comparing the New Anti-cancer Drug Eribulin With Chemotherapy Against the Usual Chemotherapy Alone in Metastatic Urothelial Cancer
PHASE3
Recruiting
184 participants
Started: Jun 28, 2021 · Completed: Aug 15, 2030
5 conditions
1 sponsor
439 locations
NCT04915755
Efficacy and Safety Comparison of Niraparib to Placebo in Participants With Human Epidermal Growth Factor 2 Negative (HER2-) Breast Cancer Susceptibility Gene Mutation (BRCAmut) or Triple-Negative Breast Cancer (TNBC) With Molecular Disease
PHASE3
Active, not recruiting
40 participants
Started: Jun 28, 2021 · Completed: Dec 31, 2025
1 condition
1 sponsor
198 locations
NCT04941248
Total-body 13N-NH3 PET/CT to Study the Blood Perfusion in Whole Body
N/A
Recruiting
25 participants
Started: Jun 27, 2021 · Completed: Dec 8, 2025
1 condition
1 sponsor
1 location
NCT05003388
Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for MS
PHASE1
Recruiting
15 participants
Started: Jun 26, 2021 · Completed: Oct 31, 2025
1 condition
1 sponsor
2 locations
NCT04824105
Modulating Anxious Coping
NA
Recruiting
80 participants
Started: Jun 26, 2021 · Completed: Jun 30, 2026
1 condition
2 sponsors
1 location
NCT04848623
Identification of Vocal Biomarkers to Monitor the Health of People with a Chronic Disease
N/A
Recruiting
50,000 participants
Started: Jun 26, 2021 · Completed: May 1, 2031
1 condition
1 sponsor
1 location
NCT04982562
Interest of the 7 Tesla MRI in the Diagnosis of Post-concussion Syndromes Among Patients With Mild Traumatic Brain Injury
NA
Recruiting
100 participants
Started: Jun 26, 2021 · Completed: Jun 26, 2024
1 condition
1 sponsor
1 location
NCT04735315
Assessment of Renal Function in Adults Born Preterm: The HAPI-Kidney Study
N/A
Active, not recruiting
157 participants
Started: Jun 26, 2021 · Completed: Dec 30, 2025
1 condition
5 sponsors
1 location
NCT05143476
Serum-Protein-Based Indices for the Progression of Fracture Healing and Nonunion
N/A
Active, not recruiting
45 participants
Started: Jun 26, 2021 · Completed: Sep 29, 2025
1 condition
2 sponsors
1 location
NCT04695080
ChariotMS - Cladribine to Halt Deterioration in People With Advanced Multiple Sclerosis
PHASE2/PHASE3
Active, not recruiting
204 participants
Started: Jun 25, 2021 · Completed: Dec 31, 2027
2 conditions
6 sponsors
22 locations
NCT05157984
Evaluation of Peroral Endoscopic Myotomy to Treat Zenker's Diverticulum
N/A
Enrolling by invitation
38 participants
Started: Jun 25, 2021 · Completed: Jun 28, 2024
1 condition
2 sponsors
1 location
NCT04798261
Study of the Long-Term Safety and Outcomes of Treating Pulmonary Embolism With the Indigo Aspiration System
N/A
Recruiting
1,500 participants
Started: Jun 25, 2021 · Completed: Feb 29, 2028
1 condition
1 sponsor
62 locations
NCT04895722
Evaluation of Co-formulated Pembrolizumab/Quavonlimab (MK-1308A) Versus Other Treatments in Participants With Microsatellite Instability-High (MSI-H) or Mismatch Repair Deficient (dMMR) Stage IV Colorectal Cancer (CRC) (MK-1308A-008/KEYSTEP-008)
PHASE2
Active, not recruiting
302 participants
Started: Jun 25, 2021 · Completed: Apr 30, 2026
1 condition
1 sponsor
109 locations
NCT04806451
Global Safety and Efficacy Registration Study of Crinecerfont in Pediatric Participants With Classic Congenital Adrenal Hyperplasia (CAHtalyst Pediatric Study)
PHASE3
Active, not recruiting
103 participants
Started: Jun 25, 2021 · Completed: Aug 31, 2027
1 condition
1 sponsor
46 locations
NCT04425967
Short Course Of Preoperative Radiotherapy in Head and Neck-, Trunk- and Extremity Soft Tissue Sarcomas
NA
Recruiting
168 participants
Started: Jun 25, 2021 · Completed: May 1, 2031
1 condition
2 sponsors
4 locations
NCT04716153
Impact of a Sensory Rehabilitation Program on Olfactory-gustatory Alterations in Patients Treated With Chemotherapy for Haematological Cancer
NA
Recruiting
54 participants
Started: Jun 25, 2021 · Completed: Dec 31, 2028
4 conditions
1 sponsor
1 location
NCT04923880
Pragmatic Implementation Trial of a CF Primary Palliative Care Intervention
NA
Active, not recruiting
643 participants
Started: Jun 25, 2021 · Completed: Jun 30, 2024
2 conditions
5 sponsors
5 locations
NCT04763616
Study of Isatuximab and Cemiplimab in Relapsed or Refractory Natural Killer/T-cell Lymphoid Malignancy
PHASE2
Recruiting
37 participants
Started: Jun 25, 2021 · Completed: Apr 30, 2026
3 conditions
2 sponsors
1 location
NCT04809363
A Study of CDPATH™ to Help Manage and Treat Crohn's Disease
PHASE4
Active, not recruiting
200 participants
Started: Jun 25, 2021 · Completed: Jun 30, 2026
1 condition
1 sponsor
44 locations
NCT04629248
A Study Evaluating the Efficacy and Safety of Obinutuzumab in Participants With Primary Membranous Nephropathy
PHASE3
Active, not recruiting
142 participants
Started: Jun 25, 2021 · Completed: Dec 23, 2027
1 condition
1 sponsor
50 locations
NCT04891016
Toripalimab Plus FLOT in Locally Advanced Gastric Cancer
PHASE2
Recruiting
60 participants
Started: Jun 25, 2021 · Completed: Dec 31, 2028
3 conditions
1 sponsor
1 location
NCT04232293
Screening of Liver Fibrosis Using Blood Tests in Patients With Type 2 Diabetes Mellitus
NA
Recruiting
806 participants
Started: Jun 25, 2021 · Completed: Mar 31, 2025
3 conditions
1 sponsor
2 locations
NCT04950803
A Randomised-controlled Trial of an Oral Microbiome Immunity Formula in Recovered COVID-19 Patients
NA
Active, not recruiting
448 participants
Started: Jun 25, 2021 · Completed: Dec 31, 2027
2 conditions
1 sponsor
1 location
NCT04604067
Assessing a ctDNA and PET-oriented Therapy in Patients With DLBCL A Multicenter, Open-label, Phase II Trial.
PHASE2
Active, not recruiting
260 participants
Started: Jun 25, 2021 · Completed: Dec 31, 2030
1 condition
1 sponsor
19 locations
NCT04993612
Postcapillary Blood Gas Analysis in Wedge Position (Wedge-BGA)
N/A
Recruiting
100 participants
Started: Jun 25, 2021 · Completed: Jun 30, 2026
1 condition
1 sponsor
1 location
NCT04925024
Evaluation of Lomecel-B™ Injection in Patients With Hypoplastic Left Heart Syndrome (HLHS): A Phase IIb Clinical Trial.
PHASE2
Active, not recruiting
40 participants
Started: Jun 25, 2021 · Completed: Aug 31, 2026
1 condition
4 sponsors
10 locations
NCT04661683
Secondhand Effects of Hookah (i.e., Waterpipe) Smoke and Aerosol
NA
Active, not recruiting
12 participants
Started: Jun 25, 2021 · Completed: Apr 15, 2026
4 conditions
1 sponsor
1 location
NCT04959734
COVID-19 Impact on RSV Emergency Presentations
N/A
Recruiting
3,000 participants
Started: Jun 25, 2021 · Completed: Jun 1, 2025
1 condition
3 sponsors
1 location
NCT04472949
Thoracic Radiotherapy Plus Maintenance Durvalumab After First Line Carboplatin and Etoposide Plus Durvalumab in Extensive-stage Disease Small Cell Lung Cancer (ED-SCLC).
PHASE2
Active, not recruiting
46 participants
Started: Jun 25, 2021 · Completed: Dec 31, 2027
2 conditions
1 sponsor
14 locations
Previous
1
More pages
1905
1906
1907
1908
1909
1910
1911
More pages
2369
Next